#CPHI22: Contract manufacturers will still be navigating global challenges into next year
The contract manufacturing business in 2022 has appeared to be humming along, despite wider global challenges. New building projects, contracts and research have been going on throughout the year.
Experts and analysts who have been watching the field have picked up on a few trends in the industry. Fiona Barry, an editor at Pharmsource, told Endpoints News that there has been talk through the industry that companies may be looking to onshore more operations, including European and US companies putting operations in domestic settings.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.